These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 38313884)

  • 1. Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response.
    Buccilli B; Rodriguez Molina MA; Redrovan Palomeque DP; Herrera Sabán CA; C Caliwag FM; Contreras Flores CJS; Abeysiriwardana CWJ; Diarte E; Arruarana VS; Calderon Martinez E
    Cureus; 2024 Jan; 16(1):e51712. PubMed ID: 38313884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
    Liu APY; Smith KS; Kumar R; Paul L; Bihannic L; Lin T; Maass KK; Pajtler KW; Chintagumpala M; Su JM; Bouffet E; Fisher MJ; Gururangan S; Cohn R; Hassall T; Hansford JR; Klimo P; Boop FA; Stewart CF; Harreld JH; Merchant TE; Tatevossian RG; Neale G; Lear M; Klco JM; Orr BA; Ellison DW; Gilbertson RJ; Onar-Thomas A; Gajjar A; Robinson GW; Northcott PA
    Cancer Cell; 2021 Nov; 39(11):1519-1530.e4. PubMed ID: 34678152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons.
    Bounajem MT; Karsy M; Jensen RL
    Neurosurg Focus; 2020 Jan; 48(1):E8. PubMed ID: 31896088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives.
    Peng Y; Mei W; Ma K; Zeng C
    Front Oncol; 2021; 11():763790. PubMed ID: 34868984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma.
    Arthur C; Jylhä C; de Ståhl TD; Shamikh A; Sandgren J; Rosenquist R; Nordenskjöld M; Harila A; Barbany G; Sandvik U; Tham E
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Applications of Liquid Biopsies in Pediatric Brain Tumors: A Systematic Literature Review.
    Greuter L; Frank N; Guzman R; Soleman J
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
    Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B
    Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
    Shields MD; Chen K; Dutcher G; Patel I; Pellini B
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening.
    Kojic M; Maybury MK; Waddell N; Koufariotis LT; Addala V; Millar A; Wood S; Pearson JV; Hansford JR; Hassall T; Wainwright BJ
    Neuro Oncol; 2023 Aug; 25(8):1507-1517. PubMed ID: 36757207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Circulating Tumor DNA in Hematological Malignancy.
    Ogawa M; Yokoyama K; Imoto S; Tojo A
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33923024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
    Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
    Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.
    Escudero L; Llort A; Arias A; Diaz-Navarro A; Martínez-Ricarte F; Rubio-Perez C; Mayor R; Caratù G; Martínez-Sáez E; Vázquez-Méndez É; Lesende-Rodríguez I; Hladun R; Gros L; Ramón Y Cajal S; Poca MA; Puente XS; Sahuquillo J; Gallego S; Seoane J
    Nat Commun; 2020 Oct; 11(1):5376. PubMed ID: 33110059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors.
    Miller AM; Karajannis MA
    J Natl Compr Canc Netw; 2022 Dec; 20(12):1363-1369. PubMed ID: 36509077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review).
    Chen H; Zhou Q
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 37052271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors.
    Yan W; Xu T; Zhu H; Yu J
    Onco Targets Ther; 2020; 13():719-731. PubMed ID: 32158224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer.
    Escudero L; Martínez-Ricarte F; Seoane J
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma.
    Li J; Zhao S; Lee M; Yin Y; Li J; Zhou Y; Ballester LY; Esquenazi Y; Dashwood RH; Davies PJA; Parsons DW; Li XN; Huang Y; Sun D
    Sci Adv; 2020 Oct; 6(42):. PubMed ID: 33067228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in lymphoma: Molecular methods and clinical applications.
    Cirillo M; Craig AFM; Borchmann S; Kurtz DM
    Cancer Treat Rev; 2020 Dec; 91():102106. PubMed ID: 33049623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.